ERBB2 and cancer: For example, the engineered Her2-bindingFc antigen binding (Fcab) clone H10-03-6 showed promising biologicalactivity against Her2-positive cancer cell lines both in vitro and in vivo,73,74 but it suffered fromrelatively low stability and its tendency to aggregate.